Fuller & Thaler Asset Management
EBS icon

Fuller & Thaler Asset Management’s Emergent Biosolutions EBS Stock Holding History

Fuller & Thaler Asset Management’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$947K Buy
112,965
+55
+0% +$460 ﹤0.01% 408
2026
Q1 		$937K Buy
112,910
+2,750
+2% +$28.5K ﹤0.01% 395
2025
Q4 		$1.36M Sell
110,160
-1,900
-2% -$20.4K ﹤0.01% 381
2025
Q3 		$988K Buy
112,060
+4,690
+4% +$36.5K ﹤0.01% 392
2025
Q2 		$685K Sell
107,370
-40,110
-27% -$230K ﹤0.01% 416
2025
Q1 		$717K Sell
147,480
-8,585
-6% -$71.1K ﹤0.01% 418
2024
Q4 		$1.49M Buy
156,065
+170
+0.1% +$1.56K 0.01% 387
2024
Q3 		$1.3M Sell
155,895
-583,930
-79% -$5.31M 0.01% 373
2024
Q2 		$5.05M Sell
739,825
-35,800
-5% -$154K 0.02% 314
2024
Q1 		$1.96M Buy
+775,625
New +$1.75M 0.01% 379
2021
Q2 		– Sell
-503,405
Closed -$46.8M – 536
2021
Q1 		$46.8M Buy
503,405
+216,671
+76% +$22.2M 0.33% 101
2020
Q4 		$25.7M Buy
286,734
+95,599
+50% +$8.77M 0.24% 120
2020
Q3 		$19.8M Buy
+191,135
New +$20.6M 0.25% 114
2019
Q2 		– Sell
-200,450
Closed -$10.1M – 466
2019
Q1 		$10.1M Buy
200,450
+6,683
+3% +$394K 0.13% 145
2018
Q4 		$11.5M Sell
193,767
-13,388
-6% -$863K 0.17% 126
2018
Q3 		$13.6M Sell
207,155
-8,879
-4% -$518K 0.14% 136
2018
Q2 		$10.9M Buy
216,034
+794
+0.4% +$41.4K 0.12% 142
2018
Q1 		$11.3M Sell
215,240
-6,400
-3% -$319K 0.13% 127
2017
Q4 		$10.3M Buy
+221,640
New +$9.33M 0.12% 122

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Fuller & Thaler Asset Management's EBS Position: Q2 2026 in Review

Fuller & Thaler Asset Management increased its Emergent Biosolutions (EBS) stake by 0.05% in Q2 2026, buying an estimated $460 and bringing the position to 112,965 shares worth $947K. The position accounts for ﹤0.01% of the portfolio, ranked #408.

Fuller & Thaler Asset Management first reported a position in EBS in Q4 2017 and has held it in 19 quarters since. The position peaked at $46.8M in Q1 2021. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Fuller & Thaler Asset Management held 112,965 shares of Emergent Biosolutions worth $947K as of Q2 2026.
  • Fuller & Thaler Asset Management bought 55 Emergent Biosolutions shares in Q2 2026, an estimated $460.
  • Emergent Biosolutions made up ﹤0.01% of Fuller & Thaler Asset Management's portfolio in Q2 2026, its #408 holding.
  • Fuller & Thaler Asset Management first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 19 quarters since.
  • Fuller & Thaler Asset Management's Emergent Biosolutions position peaked at $46.8M in Q1 2021.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.